Immunology Clinical Trials Update: Week 33, 2026

Published August 14, 2026 — 5 trials covered

By Victor Lafforgue, Founder of TrialsAlert. Blog posts are AI-drafted from ClinicalTrials.gov source data and reviewed by the editorial team. See our editorial policy for details.

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)

This Phase 3 trial investigates a new treatment called PURETHAL Mites Mixture for adults who suffer from moderate to severe allergic rhinitis caused by house dust mites. Unlike treatments that only ease symptoms, this therapy aims to modify the disease itself, potentially offering longer-lasting relief. Over 600 patients from several European countries took part, including those with and without asthma, making this study relevant to many people living with these allergies.

Efficacy and Safety of MK-6194 in Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)

This Phase 2 study focused on MK-6194, a drug being tested for adults with systemic lupus erythematosus, an autoimmune condition where the immune system attacks the body. The trial looked at how well the drug works and its safety compared to current treatments. Results from this international study provide valuable information that could lead to new treatment options for people with lupus.

Multi-Food Oral Immunotherapy for Peanut and Tree Nuts

This trial explores a new oral treatment approach for children with allergies to peanuts and tree nuts. The goal is to help children build tolerance to these foods, which could reduce the risk of severe allergic reactions. Conducted in Poland, the study compares this therapy to the usual method of avoiding these allergens, potentially offering a way to improve daily life for affected children and their families.

Flu Vaccine Response in Patients on Biologic Therapies

This Phase 2 trial examines whether a booster shot of the flu vaccine can improve protection in children who have autoimmune diseases and are receiving immune-suppressing treatments. Since these children are more vulnerable to infections, finding better ways to protect them from the flu is important. The study was completed at a U.S. site and its results could guide future vaccination strategies for these patients.

Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study

This study looks at how liver transplant patients’ immune systems respond to herpesvirus infections, which are common and can cause serious complications after transplant. By understanding these immune responses better, the research aims to help develop safer and more effective treatments for transplant recipients. The study is ongoing in Denmark and involves around 80 adult liver transplant patients.

TrialsAlert subscribers received the full impact-classified briefing and doctor-ready report this week. Get weekly briefings at trialsalert.com.